Key takeaways
- High insulin also lowers SHBG, which can flatter a total testosterone result in exactly the men who are impaired — so order SHBG alongside it.
- A large randomised trial found testosterone treatment on top of a lifestyle programme reduced progression to type 2 diabetes in men who were already metabolically impaired — on top of a programme, not instead of one.
- Visceral fat contains aromatase, the enzyme that converts testosterone into estradiol.
- Ordering total testosterone without SHBG in a man with central adiposity is how this gets missed.
Low testosterone and insulin resistance are so frequently found together that it is worth asking which one is the problem. The answer, unhelpfully and importantly, is that each one causes the other. That is not a fudge — it is the single most useful fact about this pair, because it explains why treating one side alone so often disappoints, and why the men who get the best results are the ones who attack both.
The loop, in one paragraph
Visceral fat contains aromatase, the enzyme that converts testosterone into estradiol. More visceral fat means more conversion, which lowers testosterone and raises estradiol, and the raised estradiol feeds back on the hypothalamus and pituitary to reduce the LH signal telling the testes to produce. Meanwhile, lower testosterone reduces lean mass — and skeletal muscle is where most glucose is disposed of. Less muscle means worse glucose handling, which means higher insulin, which promotes more fat storage, particularly visceral. Which contains more aromatase.
That is a closed loop with no obvious entry point, and it runs slowly enough that most men never notice it starting. What they notice is the outcome, usually somewhere in their forties: strength flat, waist up, energy down, and a fasting glucose that has drifted from "fine" to "we'll watch that."
How low testosterone worsens insulin sensitivity
- Less muscle to dispose of glucose. Skeletal muscle is the largest sink for blood glucose. Losing it removes capacity, and the capacity is not replaced by anything else.
- More visceral fat. Testosterone influences where fat is stored. Lower levels shift storage toward the abdominal and visceral compartment, which is the metabolically active, inflammatory kind.
- Reduced mitochondrial function in muscle, meaning less fuel is oxidised for the same amount of substrate delivered.
- Higher inflammatory tone. Inflammatory cytokines interfere with insulin signalling directly, at the receptor.
- Less training capacity. A man who recovers badly trains less, and training is one of the strongest insulin-sensitising interventions available.
How insulin resistance suppresses testosterone
- Aromatisation. More visceral fat, more conversion of testosterone to estradiol.
- Feedback suppression. The resulting estradiol reduces the gonadotropin signal from above, so the testes are asked for less.
- SHBG falls. High insulin suppresses hepatic SHBG production. This produces one of the most misread lab pictures in men's health, and it deserves its own paragraph.
- Direct Leydig cell effects. The testicular machinery itself appears to function less well in a hyperinsulinaemic, inflamed environment.
On the SHBG point: because insulin resistance lowers SHBG, an insulin-resistant man can show a total testosterone that looks acceptable while his production is genuinely impaired — the total is propped up by a shift in what is bound. Ordering total testosterone without SHBG in a man with central adiposity is how this gets missed. See free vs total testosterone for why the fractions matter.
What the randomised evidence shows
This is one of the areas where the trial data is genuinely strong, and it is a testosterone trial rather than a drug-comparison — so it can be reported directly.
A large Australian randomised, placebo-controlled trial enrolled men with prediabetes or newly diagnosed type 2 diabetes and gave all of them a lifestyle programme, then randomised them to testosterone or placebo on top of it. At two years, the testosterone arm had a lower rate of type 2 diabetes than the lifestyle programme alone (Wittert et al., Lancet Diabetes Endocrinol 2021).
Two things about that result are worth holding onto. The first is that it was on top of a lifestyle intervention, not instead of one — everybody got the diet and exercise programme. The second is that it is a prevention finding in men who were already metabolically impaired; it is not a licence for treating men with normal testosterone and normal glucose.
The clinical pearl: in a man with central adiposity, fatigue and low libido, ordering testosterone without a metabolic panel — or a metabolic panel without testosterone — will give you half the picture and a treatment plan built on it. Fasting insulin belongs on that panel; it moves years before HbA1c does. See insulin sensitivity, the master marker.
Where to break the loop
Because it is a loop, any genuine intervention helps the whole circuit — which is more encouraging than it sounds. The most reliable entry points, in rough order of leverage:
- Resistance training. It builds the tissue that disposes of glucose, and it improves insulin sensitivity in that tissue independently of how much muscle is added. This is the single highest-leverage item on the list. A structured programme beats improvised sessions — the 3-day full-body plan is the usual starting point for someone re-entering training.
- Protein sufficiency. The training signal is only usable if the substrate is there. Around 1.6 g/kg of goal body weight is the commonly used target. The high-protein recipe pack exists because this is where most people actually fail.
- Visceral fat reduction. Removing aromatase-containing tissue attacks the loop at its source, which is why weight loss so often raises testosterone without any hormonal intervention at all.
- Sleep. It sits upstream of both sides — testosterone is produced during sleep, and short sleep measurably worsens glucose handling. See testosterone and sleep architecture.
- Walking after meals. Unglamorous, and one of the most effective things available for post-meal glucose.
Where the loop is entrenched and testosterone is genuinely low, treating the hormone can be what makes the rest of the list executable — a man who cannot recover from training cannot train his way out. That is a clinical decision after evaluation, not a conclusion from an article; the 60-second assessment is the route to a physician who can order the right panel.
What to measure
- Total and free testosterone with SHBG, drawn between 7 and 10 a.m. on two separate mornings
- Fasting insulin — the most underused test in metabolic medicine and the earliest mover here
- Fasting glucose and HbA1c, which together with insulin give you HOMA-IR
- Triglyceride-to-HDL ratio, a free proxy already sitting on any lipid panel
- Waist circumference, which tracks the visceral compartment better than weight does
- ApoB, because the cardiovascular risk travels with this picture — see ApoB, the real number
Bottom line
Low testosterone and insulin resistance are two ends of one loop: visceral fat aromatises testosterone away and suppresses the signal from above, while low testosterone costs the muscle that disposes of glucose. Randomised evidence shows testosterone treatment on top of a lifestyle programme reduced progression to type 2 diabetes in men who were already impaired — on top of, not instead of. Break the loop wherever you can reach it: lift, eat enough protein, sleep, walk after meals, and measure fasting insulin alongside testosterone and SHBG rather than either one alone. Half a panel produces half a plan.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
